Navion received an undisclosed amount of funding to advance therapies targeting sodium and other ion channel mutations for the treatment of rare genetic epilepsies.
Navion received an undisclosed amount of funding to advance therapies targeting sodium and other ion channel mutations for the treatment of rare genetic epilepsies.